Home › Studies › PRJEB33603
PRJEB33603 ERP116409

Pediatric Crohn's disease gut microbiome during EEN, Canada

A metagenomic approach to diagnosis, induction and maintenance of deep remission following exclusive enteral nutrition in pediatric Crohn’s Disease

139 fecal samples from pediatric Crohn's disease patients (age 8-15) in Canada, collected longitudinally up to 96 weeks during exclusive enteral nutrition to study gut microbiome changes linked to treatment remission. machine-written summary

139 samples · 139 runs · CA · Child · 2019 · 24.2 Mbp / sample

Sources
✓Sequence archive 1,272○Abstract / description✓Full text 280○Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive1,272 sample values (collection date, country, health condition, health condition detail, latitude, location region, longitude, sex)
○ Abstract / descriptionread; no usable statement
✓ Full text280 sample values (age, location locality, location site) · PMC7301407
○ Supplementary tablesfiles read; no table could be matched to the samples
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Interventions

intervention — arms not resolved

Controlled / prescribed diet or feeding regimen design observational_with_procedure · population crohns_disease · Exclusive enteral nutrition (EEN) induction therapy

“treatment with EEN” — abstract:31961432 (study level; per-sample arms are in the intervention column below)

Samples at a glance
1 sampling locations · 1 country
Age
child138
adolescent1
Condition
crohns_disease139
Sex
male104
female35
Country
CA139
Body site
primary139
Collected 2013–2018
2013: 1 samples2014: 31 samples2015: 53 samples2016: 38 samples2017: 13 samples2018: 2 samples20132018
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)this project, 0–0.03 Gbp: 103 samplesall projects, 0.03–0.1 Gbp: 17,066 samples (3 %)this project, 0.03–0.1 Gbp: 36 samplesall projects, 0.1–0.3 Gbp: 29,179 samples (5 %)all projects, 0.3–1 Gbp: 47,044 samples (8 %)all projects, 1–3 Gbp: 124,983 samples (22 %)all projects, 3–10 Gbp: 253,728 samples (44 %)all projects, 10–30 Gbp: 72,533 samples (13 %)all projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 0.02 Gbp per sample0130Gbp
Sampling design and relatedness

longitudinal

20 of 22 people sampled more than once (137 samples; median 7, up to 10 per person) · follow-up median 20 mo (max 2.0 y) · median interval between samples 3 mo (time from collection dates). Schedule stated by the source: “Fecal samples from same patients at baseline and multiple follow-up points up to 96 weeks” (time origin: treatment_start); stated follow-up 22 mo.

CD001CD001: day 0CD001: day 38CD001: day 114CD001: day 255CD001: day 325CD001: day 387CD001: day 633CD002CD002: day 0CD002: day 126CD002: day 203CD003CD003: day 0CD003: day 122CD003: day 199CD003: day 486CD004CD004: day 0CD004: day 113CD004: day 163CD004: day 260CD004: day 356CD004: day 379CD004: day 614CD004: day 733CD005CD005: day 0CD005: day 118CD005: day 179CD005: day 265CD005: day 403CD006CD006: day 0CD006: day 97CD006: day 167CD006: day 254CD006: day 349CD006: day 461CD006: day 553CD006: day 629CD007CD007: day 0CD007: day 119CD007: day 193CD007: day 282CD007: day 498CD007: day 587CD008CD008: day 0CD008: day 170CD008: day 282CD008: day 337CD008: day 589CD008: day 669CD011CD011: day 0CD011: day 301CD011: day 362CD013CD013: day 0CD013: day 95CD013: day 172CD013: day 244CD013: day 298CD013: day 455CD013: day 496CD013: day 606CD013: day 701CD015CD015: day 0CD015: day 37CD015: day 59CD015: day 234CD015: day 292CD015: day 377CD015: day 607CD015: day 612CD015: day 696CD015: day 702CD017CD017: day 0CD017: day 61CD018CD018: day 0CD018: day 25CD018: day 57CD018: day 121CD018: day 212CD018: day 290CD018: day 401CD018: day 486CD018: day 575CD018: day 669CD019CD019: day 0CD019: day 31CD019: day 65CD019: day 133CD019: day 217CD019: day 456CD019: day 6160 d6 mo12 mo18 mo2.0 y

Each row is one person (14 shown of 20); dots are samples at days since that person's first sample.

How longitudinal and relatedness information is derived

Community composition

No Sandpiper profile for this project's samples yet.

Field coverage
fieldsamplescoverageR1R2R3R4
age_category139 100%
country139 100%139
health_condition139 100%139
subject_id139 100%139
detailed_location139 100%
health_condition_detail139 100%139
latitude139 100%139
location_locality139 100%139
location_region139 100%139
location_site139 100%139
longitude139 100%139
sex139 100%139
collection_date138 99%138
timepoint_label22 16%22
age_at_collection_days2 1%2
Papers (2)
  • Bacterial Taxa and Functions Are Predictive of Sustained Remission Following Exclusive Enteral Nutrition in Pediatric Crohn's Disease. 2020 PMID 31961432 PMC7301407 own_data
  • Baseline gut microbiome features associated with fecal calprotectin response to exclusive enteral nutrition in pediatric Crohn's disease. 2026 PMID 42339293 PMC13284047 unsure
Details
Archive description

Induction of remission in pediatric Crohn’s disease (CD) patients by exclusive enteral nutrition (EEN) extensively involves the gut microbiome. In this follow-up study of pediatric CD patients undergoing treatment with EEN, we employ machine learning models trained on baseline gut microbiome data to distinguish those that achieved sustained remission (SR) and those who relapsed (non-SR) after 24 weeks. We collected robust clinical data from patients at each timepoint. A total of 139 fecal samples were obtained from 22 patients (age 8-15) for up to 96 weeks. Gut microbiome taxonomy was assessed by 16S rRNA gene sequencing and functional capacity was assessed by metagenomic sequencing. We used standard metrics of diversity and taxonomy to quantify differences between SR and non-SR patients, and to associate gut microbial shifts with fecal calprotectin (FCP), and disease severity as quantified by wPCDAI. We used microbial datasets in addition to clinical metadata in random forests (RF) models to classify treatment response and predict FCP levels.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of child and adolescent by sonnet_x2 with confidence 0.68. Assay shotgun_dna.

  • host run.scientific_name · “Homo sapiens”
  • body site study.description · “139 fecal samples were obtained”
  • life stage study.description · “22 patients (age 8-15)”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMEA5883261age_at_collection_days2922.0R30.80paper.body.TABLE 1.[Age at Baseline]8
SAMEA5883198collection_date2014-10-26R10.90biosample.attribute:collection_date2014-10-26
SAMEA5883198countryCAR10.90sample.attr.geographic_location_country_and_or_seaCanada
SAMEA5883198health_conditioncrohns_diseaseR10.90biosample_attrCrohn's Disease
SAMEA5883198health_condition_detailCrohn's DiseaseR10.90sample.attr.gastrointestinal_tract_disorderCrohn's Disease
SAMEA5883198latitude44.6372R10.90biosample.attribute:geographic_location_latitude+geographic_location_longitude44.63716 -63.584014
SAMEA5883198location_localityHalifaxR30.70paper.fulltext.methodsIWK Health Centre (Halifax, NS, Canada)
SAMEA5883198location_regionNova ScotiaR10.60biosample.attribute:geographic_location_latitude+geographic_location_longitude44.63716 -63.584014
SAMEA5883198location_siteIWK Health CentreR30.70paper.fulltext.methodsIWK Health Centre (Halifax, NS, Canada)
SAMEA5883198longitude-63.5840R10.90biosample.attribute:geographic_location_latitude+geographic_location_longitude44.63716 -63.584014
SAMEA5883198sexmaleR10.90sample.attr.host_sexmale
SAMEA5883198subject_idCD001R10.85sample.attr.host_subject_idCD001
SAMEA5883202timepoint_labelbaselineR10.70sample.name_rule:aliasCD001-B
Sequencing

139 runs over 139 samples · mean 22.5 Mbp per run (median 24.2 Mbp, total 3.13 Gbp; 139 runs with a base count) · layout PAIRED 139 · platform ILLUMINA 139 · models NextSeq 550 (139) · 0% of runs with a Sandpiper profile · first public 2019-10-01

Authors (9)

Jones CMA first · Connors J · Dunn KA · Bielawski JP · Comeau AM · Langille MGI · Van Limbergen J last · Zheng H first · Chen W last

Downloads

PRJEB33603.csv.gz (4.8 KB) · parquet (77.5 KB) — all 139 samples, every field with route and confidence · PRJEB33603_determinations.csv.gz (9.8 KB) — 1,552 evidence rows

Samples (139 · every field this project has values for · hover a cell for its source)
Loading the sample table…